Related Experiment Video

Updated: Jul 14, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

[Therapeutic use of interferons and their toxicity. Focus on peripheral neuropathy]

Nicola Dentale, Roberto Manfredi

    Recenti Progressi in Medicina
    |June 22, 2007
    PubMed

    Insights

    Interferon therapy can cause peripheral neuropathy, a potentially severe side effect. Increased use of interferons necessitates careful monitoring for this adverse event.

    Area of Science:

    • Neuroscience
    • Immunology
    • Pharmacology

    Background:

    • Interferons (IFNs) are used to treat various conditions, including viral hepatitis, malignancies, and autoimmune diseases.
    • Peripheral neuropathy (PN) is an emerging adverse event associated with IFN therapy.
    • Risk factors for IFN-induced PN include underlying diseases like chronic viral hepatitis, HIV, and autoimmune disorders.

    Discussion:

    • The pathogenesis of IFN-induced PN is often immune-mediated, though direct or indirect drug effects are possible.
    • The incidence of reported PN cases is increasing with broader therapeutic indications and new IFN formulations.
    • Concurrent medical conditions can exacerbate the risk and complexity of IFN-associated PN.

    Key Insights:

    • Peripheral neuropathy is a significant tolerability concern with interferon treatments.
    • Immune-mediated mechanisms are strongly implicated in the development of interferon-induced peripheral neuropathy.
    • The rising use of interferons across diverse diseases warrants heightened vigilance for neurological adverse events.

    Outlook:

    • Further research is needed to elucidate the precise pathogenetic mechanisms of interferon-induced PN.
    • Developing predictive biomarkers for patients at high risk of PN could improve patient outcomes.
    • Enhanced clinical monitoring protocols are essential for early detection and management of peripheral neuropathy in patients receiving interferons.

    Related Concept Videos

    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
    Diabetic Neuropathy01:22

    Diabetic Neuropathy

    DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
    Drug Toxicity: Overview01:00

    Drug Toxicity: Overview

    Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
    Drug Toxicity: Dose-Dependent Reactions01:24

    Drug Toxicity: Dose-Dependent Reactions

    Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
    Diphtheria01:28

    Diphtheria

    Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...